<DOC>
	<DOCNO>NCT02451579</DOCNO>
	<brief_summary>A double-blind , placebo control study conduct single study site . Evaluating role systemic antihistamine therapy reduction adverse effect associate topical 5-aminolevulinic acid photodynamic therapy .</brief_summary>
	<brief_title>A Clinical Trial Evaluating Role Systemic Antihistamine Therapy Reduction Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Age &gt; 18 Subjects 520 actinic keratosis face Patients undergoing photodynamic therapy ( PDT ) face AK 5aminolevulinic acid ( ALA ) activate blue light . Must willing give sign HIPPA form , photo consent inform consent form . Must willing comply study dose complete entire course study . Female patient either nonchildbearing potential define : 1 . Having uterus 2 . No menses least 12 month . Or ; ( WOCBP ) woman childbearing potential must agree use effective method birth control course study , : 1 . Oral contraceptive pill , injection , implant , patch , vaginal ring , intrauterine device 2 . Intrauterine coil 3 . Bilateral tubal ligation 4 . Barrier method use additional form contraception ( e.g. , sponge , spermicide condom ) 5 . Abstinence ( If practice abstinence must agree use barrier method describe ( ) become sexually active ) . 6 . Vasectomized partner g. Negative urine pregnancy test result Baseline prior study entry ( applicable ) Presence incompletely heal wound treatment area Presence know suspect BCC SCC treatment area Previous PDT treatment face topical cytotoxic immunomodulatory agent AKs within past 6 month Coexisting potentially confound skin condition within treatment area ( e.g . eczema , psoriasis , XP , rosacea ) investigator 's discretion Presence tattoo and/or scar treatment area investigator opinion would interfere study assessment Subjects known photosensitivity take photosensitize medication list : 1 . Oral diabetes medicine 2 . Griseofulvin 3 . Thiazide diuretic 4 . Sulfonylureas 5 . Phenothiazines 6 . Tetracycline 's 7 . St. John 's Wort Use oral/topical retinoids within 1 month Baseline Subjects history sensitivity porphyrins Subjects recently excessive exposure treatment area sunlight artificial UV light ( e.g . : use tan beds/booths and/or sunbathe ) expectation tan time study Female subject pregnant , nursing infant planning pregnancy study [ throughout course study Presence evidence condition opinion investigator might impede subject 's ability give consent comply protocol requirement . Current participation participation within 30 day prior start study drug investigational research study History noncompliance clinical research protocol Ablative laser resurface face within 12 month Nonablative laser light procedure face within past 3 month Microdermabrasion ( light medium skin peel ) treatment face within past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Actinic Keratoses</keyword>
	<keyword>Photodynamic Therapy</keyword>
	<keyword>PDT</keyword>
	<keyword>Blue Light</keyword>
</DOC>